Related Experiment Videos
[Clonidine versus a placebo trial in manic disorder]
M C Hardy-Bayle1, Y Lecrubier, S Lancrenon
1Travail du Service du Pr D. Widlöcher, U 302, Hôpital de la Salpêtrière, Paris.
L'Encephale
|November 1, 1989
Summary
Clonidine showed a trend towards efficacy in treating manic inpatients, though not statistically significant compared to placebo. The study highlights the impact of locked ward hospitalization on patient outcomes.
Area of Science:
- Psychiatry
- Clinical Pharmacology
Background:
- Manic episodes require effective pharmacological interventions.
- The role of adjunctive treatments in inpatient psychiatric settings needs further exploration.
Purpose of the Study:
- To evaluate the efficacy of clonidine as a treatment for acute manic episodes.
- To compare clonidine's effectiveness against a placebo in a controlled inpatient environment.
Main Methods:
- A 14-day, double-blind, randomized study involving 24 manic inpatients.
- Dosage of clonidine started at 0.225 mg/day, increased to 0.450 mg/day if needed.
- Patients were housed in a locked ward setting.
Main Results:
- A trend for improved efficacy of clonidine over placebo was observed.
- Statistical significance was not reached due to substantial placebo response.
- The impact of locked ward hospitalization on patient improvement was noted.
Conclusions:
- Clonidine may offer a potential therapeutic option for mania, warranting further investigation.
- The significant placebo effect underscores the complexity of manic patient response in controlled settings.
- Hospitalization environment significantly influences treatment outcomes in manic patients.